A Review of the Radioconjugates Landscape
- Overview of the preclinical and clinical evolution of radioconjugates and radioimmunoconjugates across therapeutic applications
- Highlights of isotope payloads, emerging targets, and investigational indications driving next-generation programs
- Upcoming clinical milestones, along with a review of key deals and companies shaping the competitive landscape